Zenas BioPharma Announces Pricing of Upsized Initial Public Offering
WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in
WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in
WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in
Thousands competed in the 15th edition of World Class for the coveted title SHANGHAI, Sept. 12, 2024 (GLOBE NEWSWIRE) — Keegan McGregor from Canada has
Thousands competed in the 15th edition of World Class for the coveted title SHANGHAI, Sept. 12, 2024 (GLOBE NEWSWIRE) — Keegan McGregor from Canada has
Bitget Acquired 1.7M Users in August, Monthly Report Highlights VICTORIA, Seychelles, Sept. 11, 2024 (GLOBE NEWSWIRE) — Bitget, the leading cryptocurrency exchange and Web3 company
AMSTERDAM, Sept. 10, 2024 (GLOBE NEWSWIRE) — The latest report from the Access to Medicine Foundation takes a first-ever look at the critical issue of